Summary
Updated Aug 31, 2026
Ozan Pamir is Chief Financial Officer of Niagen Bioscience, Inc. (NAGE). 5 SEC Form 4 filings on record going back to 2024, most recently on 8 July 2026. Most recent open-market trade: bought $15K of NAGE on 17 November 2025. Lifetime open-market purchases: $67K.
Recent Transactions
4Every recent SEC Form 4 transaction Ozan Pamir has reported, most recent first.
Other Insiders Active in the Same Stocks
Insiders who have reported open-market trades at the same companies as Ozan Pamir. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Frank L. Jaksch Jr. - $230K of NAGE open-market activity on record
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is Ozan Pamir?
Ozan Pamir is a corporate insider, tracked as Chief Financial Officer of Niagen Bioscience, Inc. (NAGE). InsiderAlpha holds 5 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Ozan Pamir submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
Has Ozan Pamir been buying or selling stock?
Recorded transactions: 3 open-market purchases ($67K) and 0 open-market sales across all tracked filings.
How accurate is Ozan Pamir's historical track record?
Across 3 tracked purchases, Ozan Pamir averaged -7.3% avg 30-day return with a 0% 30-day win rate.
Where can I see all of Ozan Pamir's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow Ozan Pamir and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial
